Drugs that contain Edaravone
1. List of Radicava Ors drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11241416 | MITSUBISHI TANABE | Edaravone suspension for oral administration |
Nov, 2039
(16 years from now) | |
| US10987341 | MITSUBISHI TANABE | Edaravone suspension for oral administration |
Nov, 2039
(16 years from now) | |
| US11478450 | MITSUBISHI TANABE | Edaravone suspension for oral administration |
Nov, 2039
(16 years from now) | |
Do you want to check out RADICAVA ORS patents from before 2022?
| Exclusivity | Exclusivity Expiration |
|---|---|
| New Product (NP) | May 12, 2025 |
Market Authorisation Date: 12 May, 2022
Treatment: Treatment of amyotrophic lateral sclerosis
Dosage: SUSPENSION;ORAL
More Information on Dosage
RADICAVA ORS family patents
4
United States
3
Japan
1
Korea, Republic of
1
China
1
Philippines
1
Israel
1
Brazil
1
Taiwan
1
Singapore
1
Argentina
1
Australia
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic